Abstract
Objective: To analyze the innovation capability of China’s biopharmaceutical industry to explore ways to enhance innovation capability. Methods: This paper firstly constructs an evaluation system of technological innovation capability of biopharmaceutical industry based on the summary of previous research. The biopharmaceutical industry data from 2014 to 2019 were used to analyze the technological innovation capacity of biopharmaceutical industry in each province and city by using factor analysis and SPSS24.0 software. Results: The top three technological innovation capacity scores of provinces and cities in 2014-2019 are Jiangsu, Shandong and Zhejiang, with 1.95, 1.62 and 1.10 respectively. Conclusion: Provinces and cities with high innovation capacity are generally concentrated in the coastal area of East China, forming a high-quality innovation region with Jiangsu, Zhejiang and Guangdong as typical representatives.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
